Showing results (221-230 of 231) with videos related to

Sort By:
Pageof 24
Advanced Healthcare Materials|December 12, 2024
Specific gFET-Based Aptasensors for Monitoring of Microbiome Quality: Quantification of the Enteric Health-Relevant Bacterium Roseburia IntestinalisYiting Zhang, Hu Xing, Runliu Li, et al.
Plos Neglected Tropical Diseases|May 14, 2026
Human resource challenges in leprosy control: A cross-sectional study in southwest border area of ChinaRuifang Song, Yong Shen, Fuying Guo, et al.
Blood Advances|March 13, 2026
Phase 1 Study of Zanubrutinib Plus Lenalidomide in Patients With Relapsed/Refractory Diffuse Large B-Cell LymphomaZheng Song, Ying Cheng, Haiyan Yang, et al.
Nature Communications|December 23, 2025
Decoding necrosome assembly: harmonizing signal amplification and attenuation through optimal RIP3 stoichiometryXiang Li, Yating Cao, Fei Xu, et al.
Nature Communications|March 28, 2023
Epitaxially grown silicon-based single-atom catalyst for visible-light-driven syngas productionHuai Chen, Yangyang Xiong, Jun Li, et al.
Clinical Neurology and Neurosurgery|April 27, 2025
Predictors for recurrent ischemic stroke in patients with watershed infarct induced by intracranial artery stenosisZhenzhen Li, Xinwei Liu, Huiling Sun, et al.
Scientific Reports|July 15, 2026
Single-sequence based gFET-aptasensors for the discrimination of apo- and holo-RBP4 in human serumHu Xing, Runliu Li, Yiting Zhang, et al.
Cellular & Molecular Immunology|October 30, 2024
Specific ECM degradation potentiates the antitumor activity of CAR-T cells in solid tumorsRui Zheng, Kuo Shen, Sixin Liang, et al.
The Lancet. Infectious Diseases|August 16, 2025
Safety and immunogenicity of novel live attenuated type 1 and type 3 oral poliomyelitis vaccines in healthy adults in the USA: a first-in-human, observer-masked, multicentre, phase 1 randomised controlled trialLaina D Mercer, Arlene C Seña, E Ross Colgate, et al.
Lancet Regional Health. Americas|July 22, 2022
Achieving high immunogenicity against poliovirus with fractional doses of inactivated poliovirus vaccine in Ecuador-results from a cross-sectional serological surveyGabriel Trueba, Vishali Jeyaseelan, Lazaro Lopez, et al.
Pageof 24